Advertisement

Topics

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Cryopyrin-Associated Periodic Syndromes,Arthritis, Juvenile Rheumatoid,Arthritis, Gouty, Date of authorisation: 23/10/2009, Revision: 22, Status: Authorised

10:35 EDT 16 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Cryopyrin-Associated Periodic Syndromes,Arthritis, Juvenile Rheumatoid,Arthritis, Gouty, Date of authorisation: 23/10/2009, Revision: 22, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Cryopyrin-Associated Periodic Syndromes,Arthritis, Juvenile Rheumatoid,Arthritis, Gouty, Date of authorisation: 23/10/2009, Revision: 22, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Cryopyrin-Associated Periodic Syndromes,Arthritis, Juvenile Rheumatoid,Arthritis, Gouty, Date of authorisation: 23/10/2009, Revision: 22, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...